MC4R Variant (c.-251G>C)

Most results on a genetics report come with years of research behind them. This one does not. The test looks at a single, rare letter change in the MC4R gene called c.-251G>C. It has been seen in only a handful of people worldwide, no published study has examined it, and genetic laboratories classify it as a variant of uncertain significance, or VUS. That label means exactly what it says: there is not enough evidence to know whether the change does anything at all.

That uncertainty is worth stating plainly, because MC4R is a well-known gene. Damaging changes inside its protein-coding region are the most common single-gene cause of severe obesity. This variant is not one of those. It sits outside the part of the gene that encodes the protein, and there is currently no evidence that it affects appetite or weight.

What MC4R Does

MC4R (melanocortin-4 receptor) is a receptor on nerve cells in the hypothalamus, the brain region that balances hunger against the body's energy stores. Signals reaching MC4R help produce a sense of fullness, so when the receptor works poorly, that fullness signal weakens and appetite runs higher.

In a landmark 2003 study of 500 people with severe obesity that began in childhood, 5.8 percent carried mutations in the MC4R coding sequence. Carriers had intense hunger (hyperphagia), faster growth in height, more lean mass, and very high insulin levels, and people with two damaged copies were more severely affected than those with one. A 2021 study that sequenced MC4R in 5,724 people from a UK birth cohort found that about 1 in 337 carried a loss-of-function coding mutation, and by age 18 these carriers weighed on average about 18 kg (39 lb) more than non-carriers.

Those findings are about changes that break the receptor protein, confirmed by laboratory tests of how well each mutant receptor works. They tell us nothing about c.-251G>C.

What This Particular Change Is

The name c.-251G>C describes the change's location: 251 DNA letters before the start of MC4R's protein-coding instructions, in a stretch called the 5' untranslated region (5' UTR). This region is copied into the gene's messenger RNA but is not translated into protein, so the change cannot alter the receptor itself. Changes in regions like this can, in principle, affect how much receptor a cell makes, but no one has tested whether this one does.

Your report prints the letters on the forward strand of chromosome 18, where the change reads C>G (position 60,372,600 in the GRCh38 reference genome). The MC4R gene is read from the opposite strand, which is why its gene-based name is G>C. The public dbSNP identifier at this position, rs1019969912, also covers a different letter change at the same spot, so this variant is identified by its gene-based name instead.

How Rare It Is

In gnomAD v4.1, a reference database of DNA from hundreds of thousands of people, this change appears 5 times among roughly 278,000 people, all of non-Finnish European ancestry, and no one in the database carries two copies. It is not listed in ClinVar, the US public database where laboratories share variant classifications, and there are no published studies of it.

Rarity on its own does not make a variant harmful. Everyone carries many rare DNA changes shared by very few other people, and the large majority have no effect on health.

Why It Is Classified as Uncertain

Laboratories classify variants using a shared framework from the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP). To call a change disease-causing, they need evidence such as the variant tracking with the condition through families, laboratory tests showing it damages the gene, or a clear excess among affected people. To call it benign, they need the opposite kind of evidence. For c.-251G>C, neither kind exists yet, so it sits in the middle.

There is one relevant piece of background. A 2003 study that mapped the core control region (promoter) of MC4R and screened it in 431 children and adults with severe obesity found that variation in that region was not a significant cause of severe obesity. So far, changes in MC4R's control regions have not been shown to cause obesity the way coding mutations do. That study did not test this exact change, so it is context rather than a verdict.

How Results Are Reported

Your report shows the two DNA letters at this position on the forward strand of chromosome 18, one inherited from each parent.

What this means for you: a C/G result is not a diagnosis and not a known risk factor. It is an open question the genetics community does not yet have enough data to answer.

What a Variant of Uncertain Significance Means

The ACMG/AMP guidelines state that a variant of uncertain significance should not be used to make clinical decisions. No change to diet, medication, screening, or family planning should rest on this result alone.

Classifications do change as evidence accumulates. In a study of more than 1.4 million people who had hereditary cancer gene testing, about 1 in 13 distinct VUS were reclassified over the study period, and 91 percent of those were downgraded to benign or likely benign rather than upgraded. That study looked at cancer genes, not MC4R, but it reflects the general pattern: most uncertain variants turn out to be harmless once more data arrive.

How This Differs From MC4R rs17782313

You may also see MC4R rs17782313 on your report. That is a different, common variant that sits near (not inside) the MC4R gene, is carried by a large share of people, and has been studied in hundreds of thousands of them; each copy nudges obesity risk up modestly. c.-251G>C is the opposite case: very rare, inside the gene's untranslated start region, and unstudied. The two results are interpreted separately.

Why You Only Need This Test Once

Your DNA at this position does not change, so there is no reason to repeat the test. What can change is the variant's classification. If you carry it, keep a copy of your report and ask your clinician to check from time to time whether it has been reclassified.

What to Do With Your Result

If your result is C/C, there is nothing to act on. If it is C/G or G/G:

• Do not change your care because of it: a variant of uncertain significance is not a basis for medical decisions. Weight, waist size, blood sugar, blood pressure, and lipids remain the markers to watch, as they would for anyone.
• Mention it if severe obesity started in early childhood: severe obesity beginning before age 5, together with extreme hunger or a family history of extreme obesity, is when guidelines suggest genetic testing for obesity genes, testing that typically covers the full MC4R coding sequence. This single position is not a substitute for that.
• Ask for a review if you carry two copies: G/G has not been seen in gnomAD, so it is reasonable to ask your clinician or a genetic counselor to look at it in context.
• Recheck the classification over time: uncertain variants are reclassified as evidence builds, most often to benign.

The honest summary is that this result is a question mark, not a warning.